News | Radiation Therapy | September 09, 2019

Accuray to Display Motion Synchronization Cancer Treatment Technologies at ASTRO 2019

Synchrony motion tracking for Radixact System, CyberKnife VOLO Optimizer among radiation therapy treatment system highlights

Accuray to Display Motion Synchronization Cancer Treatment Technologies at ASTRO 2019

September 9, 2019 — Accuray announced that it will showcase its motion-synchronization cancer treatment technologies at the upcoming 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 15 - 18 in Chicago. The company will provide multiple opportunities for attendees to explore its new innovations in patient-first cancer treatments, including booth presentations and demonstrations at its Innovation Pavilion and presentations at the Accuray Symposium.

Synchrony Motion Tracking and Correction Technology for the Radixact System to be Unveiled

Accuray has brought its Synchrony motion synchronization technology from the CyberKnife System to the Radixact System. During the meeting, attendees will have the chance to learn how Synchrony for Radixact synchronizes the treatment delivery beam with the movement of the tumor, accurately delivering high doses of radiation directly to the tumor and minimizing dose to healthy tissue, all while the patient breathes naturally. 

Faster Radiation Treatments with the CyberKnife System

Meeting attendees can also hear more about the CyberKnife VOLO Optimizer, a next-generation optimizer that enables physicians to significantly improve operational efficiency by reducing both the time to create high quality treatment plans and the time it takes to deliver patient treatments. Clinicians now have an option for delivering the same highly precise radiosurgery and stereotactic body radiation therapy (SBRT) treatments of the CyberKnife System, more quickly and for a wider range of patient cases.

Accuray Symposium: Clinicians to Share Treatment Perspectives

At Accuray's Symposium event on, ASTRO meeting attendees will hear how dynamic tracking and motion synchronization has translated into improved patient outcomes. The symposium panelists will discuss their perspectives and share best practices on how they have used Accuray's motion synchronization technologies.

Symposium panelists will include:

  • Symposium Chairman and Introduction: Iris C. Gibbs, M.D., FACR, FASTRO, Stanford University Medical Center, Stanford, Calif.;
  • Clinical Value of Motion Synchronization for Prostate SBRT: Ronald C. Chen, M.D. MPH, University of North Carolina, Chapel Hill;
  • Clinical Value of Motion Synchronization for Lung SBRT: Jonathan W. Lischalk, M.D., Medstar Georgetown University Hospital, Washington, D.C.; and
  • First Site Experience on Real-time Motion Synchronization on the Radixact System: X. Allen Li, Ph.D., DABMP, FAAPM, Medical College of Wisconsin.

Accuray will also feature ongoing interactive discussions with industry experts in its AERO Academy. 

For more information: www.accuray.com

Related Content

Nuclear imaging equipment growth in 2020
News | Nuclear Imaging | February 14, 2020
February 14, 2020 — The nuclear imaging equipment
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.
Elekta Unity MR Linac system
News | Radiation Oncology | January 30, 2020
January 30, 2020 — Elekta announced that it signed a contract wit
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
Lung cancer patients who are inactive prior to chemoradiation are less likely to tolerate treatment and more likely to see their cancer return
News | Lung Cancer | January 08, 2020
January 8, 2020 — Numerous ...